Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

51.000
+1.3602.74%
Volume:37.24M
Turnover:1.87B
Market Cap:211.40B
PE:37.66
High:51.000
Open:49.500
Low:48.620
Close:49.640
52wk High:51.550
52wk Low:28.480
Shares:4.15B
HK Float Shares:4.15B
Volume Ratio:0.90
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.354
ROE:11.64%
ROA:6.88%
PB:3.83
PE(LYR):37.66
PS:8.31

Loading ...

Movement Alert|WUXI BIO Rises 3.08% in Regular Trading, CXO Sector Recovery Signals Strengthened by Peer Earnings Beat and Acquisition Expansion

Market Focus
·
Aug 11

CRO Sector Surges as Wuxi Apptec Secures US Court Injunction, Suspending Defense Department Listing

Stock News
·
Aug 10

HK Movers | Pharma Stocks Jump With Viva Biotech up 15%, WuXi XDC, WuXi Biologics up 6%

Tiger Newspress
·
Aug 10

Stock Track | WUXI BIO Soars 5.10% Intraday on Acquisition Deal and Sector Tailwinds

Stock Track
·
Aug 10

Movement Alert|WUXI BIO Rises 4.75% in Regular Trading, CXO Sector Momentum Continues Amid Acquisition and Earnings Catalysts

Market Focus
·
Aug 10

Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust

Stock News
·
Aug 07

Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts

Stock News
·
Aug 07

WuXi Bio Co., Ltd. gains nearly 6% in early trading, plans to acquire ChuangSheng Pharma's process development and manufacturing base in Hangzhou

Deep News
·
Aug 07

Movement Alert|WUXI BIO Rises 3.19% in Regular Trading, CXO Sector Rallies on Strong Peer Earnings and Upcoming Interim Results

Market Focus
·
Aug 07

Transcenta Agrees to Sell CDMO Assets to WuXi Biologics Unit for RMB 190 Million

Reuters
·
Aug 07

Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million

Reuters
·
Aug 06

Wuxi Biologics (Cayman) Stock Advances 1.9% in Hong Kong

Dow Jones
·
Aug 06

Movement Alert|WUXI BIO Rises 3.1% in Regular Trading, CXO Sector Strength and Interim Earnings Expectations Serve as Catalysts

Market Focus
·
Aug 06

Wuxi Biologics (Cayman) Stock Climbs 4.3% in Hong Kong

Dow Jones
·
Aug 04

CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance

Stock News
·
Aug 04

Hong Kong Market Opens Higher as Pharma and Tech Stocks Lead Gains

Stock News
·
Aug 04

Movement Alert|WUXI BIO Rises 4.85% in Regular Trading, CXO Sector Broad Rally Lifts Life Sciences Stocks

Market Focus
·
Aug 04

Wuxi Biologics (Cayman) Stock Rallies 2.5% in Hong Kong

Dow Jones
·
Jul 31

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

Movement Alert|WUXI BIO Rises 3.07% in Regular Trading, CXO Sector Rallies on Accelerating Industry Recovery

Market Focus
·
Jul 31